Uniting Experts to Propel Bench-to-Bedside Research

UC San Diego Executive Director of Real Estate Jeff Graham, Senior Director of San Diego Leasing - BioMed Realty Kevin Tremblay, Vice President of Development of BioMed Realty Pico Mina, Merits and Co-founder of BioMed Realty Alan Gold, UC San Diego Chancellor Pradeep K. Khosla, CEO & President of BioMed Realty Tim Schoen, President & CEO of Biocom  Joe Panetta, Director of UC San Diego Moores Cancer Center Scott Lippman, UC San Diego Campus Architect Joel King (Courtesy: F&L Media)

The construction of the Center for Novel Therapeutics is officially underway after a groundbreaking ceremony on Tuesday.  The Center will serve as a hub of collaboration across disciplines and industries to promote the creation of new personalized therapeutics and shorten the time required to bring these new discoveries to clinical trials.  At the groundbreaking, Chancellor Khosla described UC San Diego’s ambitious research goals, including finding new cures and eradicating disease, like cancer.  The Chancellor also emphasized how this center’s foundation of interdisciplinary collaboration and public-private partnership are crucial ingredients to this center’s bench-to-bedside research focus.